Location: Home
  • search
  • go
  • Relate News
  • 10/23/2023Merck Drops Co-development of Two ADCs from Sichuan Kelun
  • 10/23/2023Sino Biological to Buy Canada's SignalChem Biotech for Up to $48M
  • 10/23/2023China Establishes National Standardized Pain Treatment Center
  • 10/19/2023NHSA: Prevailing Generic Drugs in VBP Equivalent to Originator Drugs i...
  • 10/19/2023CDE Issues Two Technical Guidelines for Liposome Drugs
  • 10/19/2023Recent Executive Moves
  • 10/18/2023MOF Drafts New Policy to Improve Internal Control of Public Hospitals
  • 10/18/2023JPO Officially Announces Initiation and Info Submission Arrangements o...
  • 10/18/2023CDE Issues the Technical Guidelines for Pharmaceutical Research of New...
  • 10/17/2023Elevar and Hengrui Announce Global License Deal for PD-1 Inhibitor Cam...
  • 10/17/2023China's BMI System Saw Its Income Up 9.3% in the First Eight Months 
  • 10/17/2023China: The New Frontier for Western CDMOs? (Contract Pharma)
  • 10/15/2023Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
  • 10/15/2023The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
  • 10/15/2023The SparX Group Enters into a Collaboration with Arovella Therapeutics...
  • 10/15/2023EpimAb and Almirall Announce Bispecific Antibody License Agreement
  • 10/12/2023MediLink, BioNTech Ink Strategic Collaboration and Worldwide License ...
  • 10/12/2023NMPA and NHC Issues No.1 Supplement of ChP (2020)
  • 10/12/2023Review of Chinese Biopharma Industry Performance in September 2023
  • 10/12/2023China Approves Trial Use of Eisai/Biogen's Alzheimer Drug in Hainan's ...
  • 10/12/2023China's Vast Opportunities In Health Care Attract Global Telemedicine ...
  • 10/10/2023China Market Opportunities for International Pharmas (Lek)
  • 10/10/2023NHSA Announces Conclusion of Expert Evaluation for 2023 DRDL Inclusion...
  • 10/10/2023Sanofi, BioMap Partner to Develop Drug Discovery AI Modules
  • 10/10/2023Bayer Pledges to Make More Investment in China
  • 10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
  • 10/9/2023NHSA Solicits Comments on Draft of the Guiding Opinions on Strengtheni...
  • 10/8/2023Recent Executive Movements
  • 10/8/2023PharmaEssentia Enters Global License Deal with WuXi Bio for a Myeloid ...
  • 10/7/2023CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • Page:58/374 Total number of articles:11212: [First][<<] [56] [57] [58] [59] [60] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group